Walleye Capital LLC Intra Cellular Therapies, Inc. Transaction History

Walleye Capital LLC

  • $54.6 Billion
  • Q1 2024

A detailed history of Walleye Capital LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 400 shares of ITCI stock, worth $27,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 14,400 97.22%
Holding current value
$27,395
Previous $1.03 Million 97.38%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $9.99 Million - $11.7 Million
155,138 New
155,138 $10.7 Million
Q3 2023

Nov 14, 2023
BUY
$52.09 - $64.1 $7.01 Million - $8.63 Million
134,655 New
134,655 $7.01 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $731,022 - $951,163
16,690 Added 7.96%
226,402 $12.3 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $182,846 - $225,913
4,149 Added 2.02%
209,712 $11.1 Million
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $4.62 Million - $6.49 Million
108,153 Added 111.03%
205,563 $9.57 Million
Q2 2022

Aug 08, 2022
BUY
$43.0 - $65.64 $1.19 Million - $1.82 Million
27,691 Added 39.72%
97,410 $5.56 Million
Q1 2022

May 16, 2022
BUY
$38.74 - $62.09 $2.01 Million - $3.22 Million
51,841 Added 289.97%
69,719 $4.27 Million
Q4 2021

Mar 03, 2022
SELL
$35.2 - $53.42 $3.05 Million - $4.62 Million
-86,547 Reduced 82.88%
17,878 $935,000
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $481,691 - $712,642
16,772 Added 19.13%
104,425 $3.89 Million
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $691,450 - $1.05 Million
23,599 Added 36.84%
87,653 $3.58 Million
Q1 2021

May 17, 2021
SELL
$30.8 - $39.51 $41,456 - $53,180
-1,346 Reduced 2.06%
64,054 $2.17 Million
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $1.53 Million - $2.11 Million
65,400 New
65,400 $2.08 Million
Q1 2020

May 15, 2020
SELL
$12.31 - $33.12 $505,547 - $1.36 Million
-41,068 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.26 - $38.49 $165,295 - $876,340
22,768 Added 124.42%
41,068 $1.41 Million
Q3 2019

Nov 14, 2019
BUY
$7.47 - $14.03 $136,701 - $256,749
18,300 New
18,300 $137,000
Q2 2019

Aug 14, 2019
SELL
$10.65 - $14.29 $80,993 - $108,675
-7,605 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$10.9 - $14.09 $82,894 - $107,154
7,605 New
7,605 $92,000

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
77.7M
Call Options Held
1.7M
Put Options Held
1.13M
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.47B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email